Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2- imidazoline, a high selectivity ligand for imidazoline I2 receptors

Neurological Research

Volumn 31, Issue 4, 2009, Pages 390-395

  Han, Zhao ^a   Xiao, Mei Juan ^a   Shao, Bei ^a   Zheng, Rong Yuan ^a   Yang, Guo Yuan ^b   Jin, Kunlin ^c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Brain; Cell death; Idazoxan; Middle cerebral artery occlusion; Rat; TUNEL

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE; CASPASE 3; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; RAT; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BENZOFURANS; BRAIN INJURIES; BRAIN ISCHEMIA; CASPASE 3; DISEASE MODELS, ANIMAL; IDAZOXAN; IMIDAZOLES; IMIDAZOLINE RECEPTORS; IN SITU NICK-END LABELING; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLIUM SALTS;

EID: 67149116505     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X444116     Document Type: Article

References (20)

1. Regunathan S, Evinger MJ, Meeley MP, et al. Effects of clonidine and other imidazoline-receptor binding agents on second messenger systems and calcium influx in bovine adrenal medulla chromafin cells. Biochem Pharmacol 1991; 42: 2011-2018
2. Regunathan S, Feinstein DL, Reis DJ. Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J Neurosci Res 1993; 34: 681-688 (Pubitemid 23150328)
3. Regunathan S, Reis DJ. Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 1996; 36: 511-544 (Pubitemid 26168708)
4. 2-imidazoline binding sites on monoamine oxidases. J Biol Chem 1995; 270: 9856-9861
5. Raddatz R, Parini A, Lanier SM. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J Biol Chem 1995; 270: 27961-27968
6. 2-imidazoline receptor ligand LSL 60101. Br J Pharmacol 2000; 130: 1767-1776
7. Gargalidis-Moudanos C, Remaury A, Pizzinat N et al. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: Regulation by I2 imidazoline ligands in intact cells. Mol Pharmacol 1997; 51: 637-643 (Pubitemid 27172991)
8. Tesson F, Prip-Buus C, Lemoine A, et al. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. J Biol Chem 1991; 266: 155-160
9. 2-imidazoline receptor binding sites. Studies in rabbit kidney membranes. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 131-138
10. Lione LA, Nutt DJ, Hudson AL. [3H]2-(2-benzofuranyl)-2-imidazoline: A new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur J Pharmacol 1996; 304: 221-229 (Pubitemid 26342693)
11. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in the rats. Stroke 1989; 20: 84-91 (Pubitemid 19040218)
12. Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10: 290-293 (Pubitemid 20096202)
13. Maiese K, Pek L, Berger SB, et al. Reduction in focal cerebral ischemia by agents acting at imidazole receptors. J Cereb Blood Flow Metab 1992; 12: 53-63
14. Ozog MA, Wilson JX, Dixon SJ, et al. Rilmenidine elevates cytosolic free calcium concentration in suspended cerebral astrocytes. J Neurochem 1998; 71: 1429-1435 (Pubitemid 28443013)
15. Olmos G, Alemany R, Escriba PV, et al. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br J Pharmacol 1994; 111: 997-1002 (Pubitemid 24148761)
16. 2 receptors, on glial fibrillary acidic protein concentration. Eur J Pharmacol 1995; 280: 205-210
17. 2-imidazoline receptors in rat liver. Br J Pharmacol 1997; 121: 901-912
18. Raasch W, Muhle H, Dominiak P. Modulation of MAO activity by imidazoline and guanidine derivatives. Ann NY Acad Sci. 1999; 881: 313-331 (Pubitemid 29349523)
19. Suzuki T, Akaike N, Ueno K, et al. MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice. Pharmacology 1995; 50: 357-362
20. Seif-El-Nasr M, Atia AS, Abdelsalam RM. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Arzneimittelforschung 2008; 58: 160-167